Atlas Trials

Inter-Individual Tumor Heterogeneity on 3D-MRE for Predicting Response to Conversion Therapy in Liver Cancer

Clinical trial NCT07716345 · NOT_YET_RECRUITING

Trial details

NCT number
NCT07716345
Sponsor
Second Affiliated Hospital of Xi'an Jiaotong University
Status
NOT_YET_RECRUITING
Study type
OBSERVATIONAL
Hepato Cellular CarcinomaIntrahepatic Bile Duct CarcinomaMetastatic Hepatocellular Carcinoma
Start date
2026-10-01
Primary completion
2029-10-01
Enrollment
100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.